TAKE Limited Returns to Profitability in H1 FY27 with Strategic Healthcare Expansion
Take Solutions Ltd · Press Release · 14 Nov 2026, 12:30 am
TAKE Limited Returns to Profitability in H1 FY27 with Strategic Healthcare Expansion TAKE Limited reported consolidated total income of ₹615.54 million and a PAT turnaround of ₹32.75 million for H1 FY27, compared to a net loss of ₹12.13 million in H1 FY26. For Q2 FY27, consolidated total income reached ₹298.52 million, while PAT surged 108.17% QoQ to ₹22.12 million from ₹10.63 million in Q1 FY27. Strategically, the company launched the TAKE.Health platform, entered India's longevity and nutraceuticals market, and established a ₹50 million Innovation Fund committed to AI, deep tech, and digital health startups.
Original exchange filing (PDF)
More announcements from Take Solutions Ltd
- Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026, along with the Limited Review Reports thereon. · 14 Nov 2026
- TAKE Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- TAKE LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 13 Nov 2026
- Take Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated .... · 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 13 Nov 2026
- Submission of Voting Results along with Scrutinizer''s Report for the 25th Annual General Meeting. · 01 Oct 2026
- Submission of Proceedings of the 25th Annual General Meeting of the Company. · 30 Sept 2026
